Immunome (IMNM) Assets (2019 - 2026)
Immunome's Assets was $565.38 million in Q2 2026, up 90.8% from $296.29 million a year earlier but down 8.8% from the prior quarter.
Powered by 
Analysis
Immunome (IMNM) Assets (2019 - 2026) Analysis & Trends
At the end of FY2025, Assets at Immunome came in at $683.19 million, up 184.4% from FY2024.
- Assets has now increased for three consecutive years, with a five-year compound annual growth rate of 72.7% (FY2020 to FY2025).
- In earlier years, Assets was $240.24 million in FY2024 (+61.7%), $148.54 million in FY2023 (+517.7%), $24.05 million in FY2022 (-58.5%) and $57.93 million in FY2021 (+30.1%).
- Quarterly Assets has moved between $24.05 million (Q4 2022) and $683.19 million (Q4 2025) over five years.
- Compared with a year earlier, Assets has increased for four straight quarters, with growth averaging 77.2% over the last eight quarters.
- The best year-over-year quarter for Assets over five years was Q2 2024 (growth of 614.9%); the worst was Q4 2022 (a decline of 58.5%).
- Per Business Quant data, IMNM's Assets in the three quarters before Q2 2026 was $619.79 million (Q1 2026), $683.19 million (Q4 2025) and $299.38 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Immunome | 2.46 Bn | 429.67 Mn | - | 565.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 565.38 Mn |
| Mar 31, 2026 | 619.79 Mn |
| Dec 31, 2025 | 683.19 Mn |
| Sep 30, 2025 | 299.38 Mn |
| Jun 30, 2025 | 296.29 Mn |
| Mar 31, 2025 | 342.69 Mn |
| Dec 31, 2024 | 240.24 Mn |
| Sep 30, 2024 | 256.90 Mn |
| Jun 30, 2024 | 296.22 Mn |
| Mar 31, 2024 | 319.75 Mn |
| Dec 31, 2023 | 148.54 Mn |
| Sep 30, 2023 | 93.16 Mn |
| Jun 30, 2023 | 41.44 Mn |
| Mar 31, 2023 | 48.11 Mn |
| Dec 31, 2022 | 24.05 Mn |
| Sep 30, 2022 | 30.55 Mn |
| Jun 30, 2022 | 39.02 Mn |
| Mar 31, 2022 | 47.73 Mn |
| Dec 31, 2021 | 57.93 Mn |
| Sep 30, 2021 | 62.56 Mn |
API Access
Immunome Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=IMNM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "IMNM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=IMNM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();